NCT02544750
- Conditions
- Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +17 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
Clinical trial condition
Tuberous Sclerosis
Explore clinical trials studying Tuberous Sclerosis. Study availability and eligibility vary by location and protocol.
88 public trials
20 recruiting studies
Tuberous Sclerosis trial results
Completed
RAPAMYCIN FOR KIDNEY ANGIOMYOLIPOMAS
NCT00126672
- Conditions
- Angiomyolipoma, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +20 more
- Locations
-
- Loma Linda University School of Medicine Loma Linda, California, United States
- Connecticut Children's Medical Center Hartford, Connecticut, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
- New York University Medical Center New York, United States
NCT03525834
- Conditions
- Angiomyolipoma, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +26 more
- Locations
-
- Novartis Investigative Site Wuhan, Hubei, China
- Novartis Investigative Site Shanghai, Shanghai Municipality, China
- Novartis Investigative Site Chengdu, Sichuan, China
- Novartis Investigative Site Beijing, China
NCT02451696
- Conditions
- Brain Diseases, Central Nervous System Diseases, Congenital Abnormalities, +17 more
- Locations
-
- New York University Langone Medical Center New York, United States
NCT01929642
- Conditions
- Autism, Autism Spectrum Disorder, Autistic Disorder, +23 more
- Locations
-
- Kennedy Krieger Institute Baltimore, Maryland, United States
- Conditions
- Brain Diseases, Brain Ischemia, CDKL5 deficiency disorder, +35 more
- Locations
-
- Phoenix Children's Hospital Phoenix, Arizona, United States
- Children's Hospital Los Angeles Los Angeles, California, United States
- Colorado Children's Hospital Aurora, Colorado, United States
- Nicklaus Children's Hospital Miami, Florida, United States
NCT01780441
- Conditions
- Autism Spectrum Disorder, Autistic Disorder, Child Development Disorders, Pervasive, +18 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- University of California at Los Angeles Los Angeles, California, United States
- Boston Children's Hospital Boston, Massachusetts, United States
- Cincinnati Children's Hospital Cincinnati, Ohio, United States
NCT01526356
- Conditions
- Angiofibroma, Angiofibromas, Congenital Abnormalities, +16 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- UCLA Mattel Children's Hospital Los Angeles, California, United States
- Jack & Julia Center for TSC at Oakland Children's Hospital & Research Center Oakland, California, United States
- Kennedy Krieger Institute Baltimore, Maryland, United States
NCT02201212
- Conditions
- Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +16 more
- Locations
-
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- Memorial Sloan Kettering Cancer Center New York, United States
Completed
Safety of Simvastatin in LAM and TSC
NCT02061397
- Conditions
- Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +24 more
- Locations
-
- University of Pennsylvania Philadelphia, Pennsylvania, United States
Related conditions
- Congenital Abnormalities (88)
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities (88)
- Genetic Diseases, Inborn (88)
- Hamartoma (88)
- Heredodegenerative Disorders, Nervous System (88)
- Malformations of Cortical Development, Group I (88)
- Neoplasms, Multiple Primary (88)
- Nervous System Malformations (88)